Clinical trial
A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)
Active, not recruiting · Phase 1 · 1 countries · Registry ID NCT07388667
What this study is about
Researchers are looking for new weight loss medicines for people with higher body weight. The study medicine, MK-4082, is different from similar weight loss medicines because people take it as a pill instead of an injection. Before giving a study medicine to people with a health condition, researchers first do studies to find a safe dose level (amount) of the study medicine that can be used in future studies. The goals of this study are to learn about: * The safety of MK-4082 and if people tolerate it * What happens to different MK-4082 dose levels in a person's body over time
Basic eligibility
Full registry criteria
Treatments and study arms
MK-4082
Oral Tablet
Placebo
Oral Tablet
Primary outcomes
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants who experience an AE will be reported.
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants who discontinue study treatment due to an AE will be reported.
Study locations
5 locations were listed when this page was built. The first 40 are shown.